Developing patient-derived organoids to demonstrate JX24120 inhibits SAMe synthesis in endometrial cancer by targeting MAT2B

MLA

Chunxue Zhang, et al. “Developing Patient-Derived Organoids to Demonstrate JX24120 Inhibits SAMe Synthesis in Endometrial Cancer by Targeting MAT2B.” Pharmacological Research, vol. 209, no. 107420-, Nov. 2024. EBSCOhost, https://doi.org/10.1016/j.phrs.2024.107420.

APA

Chunxue Zhang, Xiaojing Lu, Ting Ni, Qi Wang, Xiaoyan Gao, Xiao Sun, Jian Li, Fei Mao, Jin Hou, & Yudong Wang. (2024). Developing patient-derived organoids to demonstrate JX24120 inhibits SAMe synthesis in endometrial cancer by targeting MAT2B. Pharmacological Research, 209(107420-). https://doi.org/10.1016/j.phrs.2024.107420

Chicago

Chunxue Zhang, Xiaojing Lu, Ting Ni, Qi Wang, Xiaoyan Gao, Xiao Sun, Jian Li, Fei Mao, Jin Hou, and Yudong Wang. 2024. “Developing Patient-Derived Organoids to Demonstrate JX24120 Inhibits SAMe Synthesis in Endometrial Cancer by Targeting MAT2B.” Pharmacological Research 209 (107420-). doi:10.1016/j.phrs.2024.107420.